According to the most recent report that Russell Investments Group Ltd submitted to the Securities and Exchange Commission (SEC), the company’s holdings in Maximus, INC (NYSE: MMS) were reduced by 28.3% over the third quarter of this year.

The company now has a total ownership stake in the health services provider’s Stock of 35,780 shares, having sold 14,127 shares during the quarter to bring the total number of shares it owns to that level.

At the end of the most recent fiscal quarter, Russell Investments Group Ltd held 0.06% of Maximus, worth $2,068,000 in the company’s portfolio.

In recent months, several other significant investors have changed the quantity of MMS stock held in their portfolios.

During the third quarter, Householder Group Estate & Retirement Specialist LLC spent close to $26,000 to acquire an additional stake in Maximus.

During the second quarter, McIlrath & Eck LLC achieved a 230.4% increase in the proportion of Maximus stock that the company owned.

McIlrath & Eck LLC now holds a total of 631 shares of the company’s stock, which has a value of $39,000, following the purchase of an additional 440 shares of the health services provider’s stock during the period in question.

This brings the total number of shares held by the company to 631.

The amount of $47,000 was contributed by Wipfli Financial Advisors LLC as a new investment in Maximus during the third quarter of 2018.

EverSource Wealth Advisors LLC made a new investment of $61,000 in the company Maximus during the second quarter of the fiscal year. Finally, during the second quarter, Eagle Bay Advisors LLC increased its holdings in Maximus by contributing approximately $61,000 to the company by purchasing additional shares.

Institutional investors such as hedge funds and other types hold a combined total of 97.41 percent of the company’s stock.
Several equity analysts have recently published reports on the company they are monitoring in their research.

The rating of Maximus was raised from a “c+” to a “b-” as a direct result of the findings of a research study that were presented in an article that TheStreet released on December 8. StockNews.com debuted its coverage of Maximus with the publication of a research study on that company the following day, on October 12 (Wednesday).

They provided a positive recommendation for the stock to trade on Thursday, the first-day trading for MMS shares.

The opening price was $75.58.

During the previous year, the share price of Maximus, INC ranged from a high of $79.78 to a low of the same amount.

The share currently trades for 22.97 times its annual earnings, has a price-to-earnings ratio of 0.71, and has a market value of $4.59 billion.

According to the moving average of the past 200 days, the stock price is currently $65.52, while the moving average of the past 50 days puts it at $72.94.

The debt-to-equity ratio comes in at 0.83, the quick ratio at 1.33, the current ratio at 1.33, and the quick ratio at 1.33.

The most recent quarterly earnings report for Maximus, which is traded on the New York Stock Exchange under the ticker symbol MMS, was published on November 21, a Monday.

The healthcare provider reported that its earnings per share (EPS) for the quarter came in at $1.40, which is 0.38 percentage points higher than the consensus estimate of $1.02.

Even though market watchers anticipated that the company would bring in sales totaling $1.09 billion for the quarter, it brought in sales totaling $1.18 billion.

Maximus had a return on equity of 17.59%, and the net margin for the company was 4.40%.

Maximus, INC is expected to generate earnings of $3.87 per share during the current fiscal year, according to projections made by industry experts.

In addition, the corporation has recently announced a quarterly dividend, which is planned to be distributed on February 28. On Wednesday, February 15, 2018, a $0.28 dividend payment will be made to all shareholders of record as of the previous day.

This results in an annual dividend payment of $1.12 and a dividend yield of 1.48% when calculated annually.

The date that the ex-dividend will take place will be on Tuesday, February 14.

There is a total payout percentage of 34.04% for wagers placed on Maximus.

Raymond B. Ruddy, a director of the company, purchased 5,730 shares of company stock on December 7, which is another development related to this topic.

The total number of shares acquired was 400,584.30, and the price of $69.91 was the average cost per share of those shares.

The director now has direct ownership of 109,030 shares, which have a combined value of $7,622,287.30 due to the acquisition. You might find a filing that explains the transaction in greater detail on the Securities and Exchange Commission (SEC) website.

In addition, David Francis, the general counsel for the company, sold 1,800 shares of the company’s stock on November 23 of this year.

The shares were sold for a total amount of $127,656.00, which is equivalent to an average price of $70.92 per share is another development related to this topic.

The total number of shares acquired was 400,584.30, and the price of $69.91 was the average cost per share of those shares.

The director now has direct ownership of 109,030 shares, which have a combined value of $7,622,287.30 due to the acquisition. You might find a filing that explains the transaction in greater detail on the Securities and Exchange Commission (SEC) website.

In addition, David Francis, the general counsel for the company, sold 1,800 shares of the company’s stock on November 23 of this year.

The shares were sold for $127,656.00, equivalent to an average price of $70.92 per share. Following the completion of the sale, the general counsel was given the authority to exercise control over 13,658 of the company’s shares, which have an estimated value of $968,625.36.

If you follow the link, which will take you to a legal file submitted to the SEC, you will have the opportunity to acquire additional information regarding the transaction.

In addition to that, on December 7, Director Raymond B. Ruddy purchased an additional 5,730 shares of the company’s stock.

A total of $400,584.30 was spent on the acquisition of the stock, which resulted in an average price of $69.91 per share paid for the transaction. Following the completion of the transaction, the director now possesses 109,030 shares of the company, the total value of which is $7,622,287.30. You should look in this location if you are looking for the disclosure that pertains to this transaction. 1.30 company insiders own a percent of the total shares currently outstanding.

The post Russell Investments Group Ltd. sells Maximus, Inc. (NYSE:MMS) stock. appeared first on Best Stocks.